RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for NSCLC
Clinical trial NCT06142058 · RECRUITING
Trial details
- NCT number
- NCT06142058
- Sponsor
- Xueqin Yang
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-13
- Primary completion
- 2026-12-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.